December 29, 2017 / 1:04 PM / 9 months ago

BRIEF-Cstone's Anti-Ctla-4 Antibody Cs1002 Filed For Clinical Trial Approval In Australia

Dec 29 (Reuters) -

* CSTONE’S ANTI-CTLA-4 ANTIBODY CS1002 FILED FOR CLINICAL TRIAL APPROVAL IN AUSTRALIA Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below